DrugPatentWatch

DrugPatentWatch Archives

You are currently viewing the 2008 archives
Click here to return to the current data set

Competitive intelligence on small-molecule drugs and the 80,000 patents covering them

Simple flat-rate subscription plans

Ultimate Plan

$495/ month or  $2,495/ year

Tradename: LOESTRIN 24 FE

Summary for Tradename: LOESTRIN 24 FE

Patents:1
Applicants:1
NDAs:1
Suppliers: see list2
drug
patent expirations by year for
 LOESTRIN 24 FE

Clinical Trials for: LOESTRIN 24 FE

Study of Loestrin 24(24 Days of "Real" Pills) Fe Versus Loestrin 1/20 (21 "Real" Pills)
Status: Completed Condition: Pelvic Pain; Headaches; Emotional

Post Operative Continuous Active Combination Sex Steroids for the Prevention of Recurrent Endometrioma Formation
Status: Withdrawn Condition: Endometrioma

Study of the Contraceptive Efficacy and Safety of a NOMAC-E2 Combined Oral Contraceptive (COC)(P06448)
Status: Completed Condition: Contraception

Courtesy of ClinicalTrials.org
See more clinical trials for this drug
Glossary
Applicant Tradename Generic Name Dosage NDA Approval Date Type RLD Patent No. Patent Expiration Exclusivity Expiration
Warner Chilcott
LOESTRIN 24 FE
ethinyl estradiol; norethindrone acetate
TABLET; ORAL021871Feb 17, 2006RXYes<disabled><disabled>
Warner Chilcott
LOESTRIN 24 FE
ethinyl estradiol; norethindrone acetate
TABLET; ORAL021871Feb 17, 2006RXYes5,552,394<disabled><disabled>
This preview shows a limited data set
Complete access is available with a Subscription
first patents previous patents next patents last patents

Export unavailable in trial.
Subscribe for complete access.

Paragraph IV activity for: LOESTRIN 24 FE

Drugname Dosage Strength RLD Submissiondate
norethindrone acetate/ ethinyl estradiol and ferrous fumarateTablets1 mg/0.02 mg and 75 mgLoestrin 24 Fe4/17/2006

« Back to Dashboard

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors.

Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided information. There is no warranty that the information contained herein is error free. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Connect with Social Media:

Follow DrugPatentWatch on Twitter Connect with DrugPatentWatch on Linkedin Drug Patents on LinkedIn

Copyright © 2002-2014 thinkBiotech LLC. ISSN: 2162-2639

Other thinkBiotech sites: BiotechUBiotechBlogJournal of Commercial Biotechnology

`abc